266 hasil
Menampilkan 1–20 · 0,34 detik · RSS
Journal of Cancer Research and Practice
ISSN 2311-3006 · Wolters Kluwer Medknow Publications · 266 artikel di indeks
-
Artikel Jurnal
Immune-related Myocarditis, Guillain–Barré Syndrome, and Myasthenia Gravis Exacerbation after Pembrolizumab Therapy in a Patient with Recurrent B3 Thymoma: A Case Report
Thymic epithelial tumors, including thymoma and thymic carcinoma, are rare malignancies for which platinum-based chemotherapy is the standard first-line treatment. Second-line options include chemotherapy, targeted therapy, immune checkpoint inhibitors (ICIs), or combination regimens. While thymoma…
-
Artikel Jurnal
Alpha-Fetoprotein-producing Neuroendocrine Carcinoma of the Pancreas with Multiple Liver Metastasis: A Case Report
Alpha-fetoprotein (AFP) is a well-known tumor marker for hepatocellular carcinoma (HCC). However, Grade 3 AFP-producing neuroendocrine tumor (NET) is a rare and aggressive cancer. We report the case of a 68-year-old female admitted for multiple liver tumors and an elevated AFP level discovered…
-
Artikel Jurnal
Impact of Early versus Delayed G-CSF Administration on Clinical Outcomes in Chemotherapy-induced Neutropenia: A Propensity Score-matching Cohort Study
Background: Chemotherapy-induced neutropenia is a significant complication in cancer treatment, increasing the risk of infection and treatment delay. Granulocyte-colony stimulating factor (G-CSF) is used to treat and prevent neutropenia; however, the optimal timing of administration remains…
-
Artikel Jurnal
Combination Therapy of Anti-PD-1 Immunotherapy and Taxanes in Relapsed and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Real-world Single-center Retrospective Study
Background: Recurrent/metastatic head and neck squamous cell carcinoma (R/M-HNSCC) carries a poor prognosis despite the current standard of care. This study aimed to investigate the efficacy and safety of a novel non-cisplatin-containing chemo-immunotherapy regimen combining a programmed cell death…
-
Artikel Jurnal
A Systematic Review of Interventions for Pain in Patients with Incurable Pancreatic Cancer
Objective: Incurable pancreatic cancer poses challenging analgesic requirements, which subsequently affect the quality of life of patients. The aim of this review was to assess the available methods of managing pain in incurable pancreatic cancer, how these are utilized, and their effectiveness in…
-
Artikel Jurnal
From Crisis to Cure: A Case Report of Pathologic Complete Response in a Young Male with BRAF-mutant dMMR Metastatic Colorectal Cancer after Immunotherapy
Metastatic colorectal cancer (mCRC) with a BRAFV600E mutation is an aggressive subtype with poor prognosis and limited response to standard chemotherapy. However, coexisting deficient mismatch repair (dMMR) is associated with improve outcomes with immunotherapy. We present the case of early-onset…
-
Artikel Jurnal
Tumor Lysis Syndrome in a Super-responder to Chemoimmunotherapy for Nasopharyngeal Carcinoma: A Case Report
We present the case of a 54-year-old male with nasopharyngeal cancer accompanied by huge liver metastasis, an extremely high Epstein–Barr virus viral load, and B symptoms. Despite aggressive hydration and close laboratory monitoring, he developed tumor lysis syndrome (TLS) and acute kidney injury…
-
Artikel Jurnal
Acquired Resistance in BRAF V600E-Mutant MSS Colorectal Cancer: Two Cases Highlighting Molecular Adaptation and Salvage Strategies
BRAF V600E mutations in metastatic colorectal cancer (mCRCs) are associated with aggressive tumor behavior and poor prognosis, with limited benefit from BRAF inhibitors due to rapid resistance mechanisms. Here, we report the two cases of microsatellite-stable, BRAF V600E-mutated mCRC demonstrating…
-
Artikel Jurnal
Treatment Outcomes in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer Patients with and without Progression after Completion of Reimbursed Cyclin-dependent Kinase 4/6 Inhibitors in Taiwan: A Single-institution Experience
Background: Combining cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) with endocrine therapy is the standard first-line treatment for metastatic hormone receptor (HR)-positive, HER2-negative breast cancer. In Taiwan, it is estimated that nearly half of the patients completing 2 years of CDK4/6i…
-
Artikel Jurnal
Unusual Presentation of Secondary Chronic Myeloid Leukemia in a Metastatic Breast Cancer Patient Receiving Cyclin-dependent Kinase 4/6 Inhibitor Therapy: A Case Report
An association between breast cancer treatment and secondary chronic myeloid leukemia (CML) has rarely been reported. In this report, we present a 62-year-old postmenopausal woman initially diagnosed with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer who subsequently…
-
Artikel Jurnal
Does Genetic Testing Influence Outcomes: Early Experience in Melanoma Case Series
Background: The treatment and prognosis of melanoma have historically been based on histologic stage and Breslow depth; however, due to the increase in surveillance, melanomas are being identified at an earlier stage and lower Breslow depth. Advances in genetic testing, such as Decision Dx®, mean…
-
Artikel Jurnal
A Long-standing Perianal Fistula Hiding an Adenocarcinoma: A Case Report
Fistula-associated anal adenocarcinoma (FAAC) is an uncommon disease. Due to the clinical similarity in the symptoms to benign anal fistulas, FAAC can confuse clinicians and lead to delayed diagnosis. We report a case of FAAC in a patient with a 20-year history of an unhealed perianal fistula and…
-
Artikel Jurnal
Pembrolizumab-induced Guillain–Barré Syndrome in Early-stage Triple-negative Metaplastic Breast Cancer Responded to Intravenous Immunoglobulin and Steroids: A Case Report
Pembrolizumab is an immune checkpoint inhibitor that blocks the PD-1 pathway on T-cells. It has been associated with a variety of immune-related adverse events, including Guillain–Barré syndrome (GBS), a rare but critical event. We report the case of a patient with early-stage metaplastic breast…
-
Artikel Jurnal
Real-world Evidence of Treatment Outcomes in Mantle Cell Lymphoma: A Single-center Experience in Southern Taiwan
Background: Mantle cell lymphoma (MCL) is a rare and aggressive B-cell lymphoma often diagnosed at an advanced stage. Standard first-line treatment includes bendamustine-rituximab or cytarabine-based regimens, sometimes followed by autologous stem cell transplantation (autoSCT). The TRIANGLE trial…
-
Artikel Jurnal
Case Report of Primary Hepatoid Lung Carcinoma in a 45-year-old Woman
A 45-year-old woman initially presented with back pain and was subsequently given a diagnosis of hepatoid adenocarcinoma (HAC) of the lung, stage IV, T3N0M1b. No actionable mutations were detected. A multidisciplinary therapeutic approach, including atezolizumab plus bevacizumab treatment…
-
Artikel Jurnal
Impact of COVID-19 on Timeliness of Receiving Systemic Therapy for Patients Diagnosed with Lung Cancer
Background: During the COVID-19 pandemic, patients newly diagnosed with lung cancer faced potential delays in accessing timely cancer treatment. Little information exists on how COVID-19 impacted the timeliness of receiving a first course of systemic therapy after a lung cancer diagnosis. Materials…
-
Artikel Jurnal
Evaluating the Impact of Primary Tumor Resection on EGFR-TKI-treated Patients with Advanced Lung Cancer: A Multicenter Propensity-matched Study
Background: Nonsmall-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is exceptionally sensitive to EGFR tyrosine kinase inhibitors (TKIs). Despite this, disease progression commonly occurs at the primary site, prompting debate on the potential advantages of…
-
Artikel Jurnal
Pembrolizumab as an Unconventional First-line Salvage Therapy in Primary Mediastinal Large B-cell Lymphoma: A Case Report
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare and aggressive subtype of non-Hodgkin lymphoma with unique clinical and molecular characteristics. We report the case of a young woman diagnosed with PMBCL who presented with a bulky mediastinal mass and responded favorably to…
-
Artikel Jurnal
Pancreatic Cancer Presenting with Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature
Thrombotic thrombocytopenic purpura (TTP) is a rare form of thrombotic microangiopathy (TMA). Cancer-related TMA typically arises from microvascular metastasis and bone marrow involvement. ADAMTS13 is a plasma protease that regulates von Willebrand factor and prevents platelet aggregation and…
-
Artikel Jurnal
Ten-year Experience and Evolving of Palliative Care at a Tertiary Medical Center in Taiwan
Background: Palliative care (PC) improves quality of life for patients with life-threatening illnesses. Despite global efforts, PC access remains limited. This study evaluated the 10-year trends of PC coverage and its impact on survival among advanced cancer patients at a tertiary medical center in…